There are now many health devices that can be implanted into consumers’ bodies to help with the monitoring their health condition. These devices can communicate health data back to data storage devices where clinicians can review and act accordingly to help maintain consumers’ health. Such advances have raised questions about privacy and consent for the […]
Family members of people diagnosed with type 1 diabetes (T1D) are at an increased risk of developing the condition themselves. Type1Screen is a free, JDRF-funded program available to any family members of a person diagnosed with T1D. Testing through Type1Screen can identify the early stages of T1D. Detecting T1D early, before symptoms develop, combined with […]
This clinical trial is investigating whether fenofibrate, a drug used to lower cholesterol, can slow or reverse eye damage in adults with type 1 diabetes. Fenofibrate has been shown to slow eye damage in type 2 diabetes, and researchers are now investigating whether the same effect will be seen in T1D. This study has been […]
Our researchers are recruiting young Australians between the ages of 14 and 17, who are diagnosed with Type 1 Diabetes and who are using continuous glucose monitoring. The course consists of 8 x 1.5-hour group sessions. The first session is scheduled for Wednesday 30th March 2022. Sessions will be delivered via Zoom and take place […]